Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 4 December 2024
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida [ID5089]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Robot-assisted surgery for orthopaedic procedures: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC